Tirzepatide

GLP-1 receptor agonists may cut risk of dementia and other conditions, study finds Hospital Pharmacy Europe15:25Alzheimer's Ozempic Health

GLP-1 weight-loss drugs may cut risk of dementia and other conditions Nursing in Practice15:46Alzheimer's Ozempic Health

Why do people with obesity, but without diabetes, start taking semaglutide? News-Medical.Net19:33Ozempic Obesity Global Health

Obesity rate drops in the U.S., healthcare experts point to GLP-1 medications as the cause WSFA TV 12, Alabama15:38Ozempic Obesity Global Health

NVO stock down as Medicare selects semaglutide drugs for price cuts Zacks15:02Novo Nordisk Ozempic Pharma

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations Yahoo! US14:48Novo Nordisk Ozempic Pharma

Scientists say drugs like Ozempic and Wegovy 'could slash risk of 42 health conditions' Manchester Evening News16:48Ozempic Diabetes Health

UK obesity rates may start falling this year thanks to weight loss jabs Manchester Evening News19:06Ozempic Diabetes Health

Warning! Weight loss jabs like Ozempic linked to deadly cancer diagnosis in the year after… MailOnline16:28Ozempic Diabetes Cancer

Weight-loss jabs linked to reduced risk of 42 conditions including dementia Yahoo! UK & Ireland17:35Diabetes Ozempic Health

Here’s why Eli Lilly stock is crashing Finance in Bold12:43Mounjaro Eli Lilly Pharma

JP Morgan 2025: Eli Lilly misses 2024 revenue estimate by $400m Pharmaceutical Technology11:40Mounjaro Eli Lilly Pharma

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says Fortune01:13FDA

Weight-loss drugs reduce risk of seizures, drug abuse and heart attacks, study finds i News16:14Ozempic Pneumonia Diet and Fitness

Managing sustainable drug spend: 5 Trends reshaping pharmacy benefits in 2025 Pharmacy Times16:33Ozempic Pharma

Misleading statements common in online ads for compounded GLP-1s TCTMD16:43Ozempic Pharma

Latest News

In the last 4 hours

Association of long-term weight management pharmacotherapy with multiple health outcomes: an umbrella review and… Nature.com13:19

Earlier today

‘Skinny jabs’ are turning slimmers teetotal – and drinks companies are feeling the loss Yahoo! UK & Ireland06:10

Yesterday

Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever. The Motley Fool16:21 25-Jan-25

Weight loss jabs made me feel so sick I thought I was going to die, reveals Danielle Mason who… MailOnline10:03 25-Jan-25

Prediction: 3 Stocks That'll Be Worth More Than Berkshire Hathaway 5 Years From Now The Motley Fool09:13 25-Jan-25

In the last 7 days

Why Eli Lilly Stock Topped the Market Today The Motley Fool22:31 24-Jan-25

14 Tips for Getting Rid of Belly Fat Men's Health21:08 24-Jan-25

Allurion shares soar 77% after sharing plans for GLP-1RA combo trial Verdict Medical Devices17:29 24-Jan-25

Semaglutide: a "wonder drug" with risks Salon.com17:03 24-Jan-25

Managing Sustainable Drug Spend: 5 Trends Reshaping Pharmacy Benefits in 2025 Pharmacy Times16:33 24-Jan-25

How nurses can support patients with obesity in primary care Nursing in Practice16:26 24-Jan-25

Novo Nordisk leaps on new obesity drug data pharmaphorum13:03 24-Jan-25

2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher The Motley Fool09:18 24-Jan-25

Dr. Daniel Benhuri Recognized as 2025 Top Patient Rated Primary Care Physician in Beverly Hills … PRWeb (Press Release)17:07 23-Jan-25

Warning! Weight loss jabs like Ozempic linked to deadly cancer diagnosis in the year after… MailOnline16:28 23-Jan-25

Pharmacy Policy: January 2025 Pharmacy Times16:22 23-Jan-25

GLP-1 receptor agonists may cut risk of dementia and other conditions, study finds Hospital Pharmacy Europe15:25 23-Jan-25

Whoopi Goldberg shows off dramatic weight loss results after weighing 21 stone The Mirror11:50 23-Jan-25

My Top 5 Stocks to Buy in Early 2025 The Motley Fool09:22 23-Jan-25

Why do people with obesity, but without diabetes, start taking semaglutide? News-Medical.Net19:33 22-Jan-25

Scientists say drugs like Ozempic and Wegovy 'could slash risk of 42 health conditions' Manchester Evening News16:48 22-Jan-25

GLP-1 weight-loss drugs may cut risk of dementia and other conditions Nursing in Practice15:46 22-Jan-25

GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares Rise Zacks13:02 22-Jan-25

It's about to get a lot harder to buy knock-off Ozempic Business Insider09:53 22-Jan-25

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says Fortune01:13 22-Jan-25

Websites Selling Compounded GLP-1 RAs Often Misinform Consumers HealthDay00:01 22-Jan-25

Aisleyne Horgan-Wallace says she almost died after buying counterfeit Ozempic on the black… MailOnline15:58 21-Jan-25

'I'm a GP and this is how to tell if you're being sold fake weight loss injections' Daily Record14:08 21-Jan-25

The Health Risks and Benefits of Weight-Loss Drugs TIME13:34 21-Jan-25

MicroAire closes deal to acquire adipose tissue biotech NEOSYAD Verdict Medical Devices12:13 21-Jan-25

Large study points to benefits - and risks - of GLP-1 drugs pharmaphorum10:40 21-Jan-25

Weight-loss jabs may have wider health benefits, study suggests Evening Standard19:50 20-Jan-25

Mounjaro Update: Week 33 The Nittany Turkey (Weblog)19:03 20-Jan-25

ASHP Midyear: Expert Discusses GLP-1 Medications and Incretin Mimetics for Diabetes Care Pharmacy Times17:40 20-Jan-25

Study Reports Dietary Recommendation for Managing GLP-1-Related Gastrointestinal Adverse Events Pharmacy Times17:40 20-Jan-25

Weight-loss jabs linked to reduced risk of 42 conditions including dementia Yahoo! UK & Ireland17:35 20-Jan-25

Misleading Statements Common in Online Ads for Compounded GLP-1s TCTMD16:43 20-Jan-25

Weight-loss drugs reduce risk of seizures, drug abuse and heart attacks, study finds i News16:14 20-Jan-25

GLP-1 Agents' Risks and Benefits Broader Than Previously Thought Medpage Today16:01 20-Jan-25

NVO Stock Down as Medicare Selects Semaglutide Drugs for Price Cuts Zacks15:02 20-Jan-25

Everything you need to know about the viral Natural Mounjaro weight-loss drink Hindustan Times13:26 20-Jan-25

Natural alternative to Ozempic? Scientist may have discovered a new mechanism that mimics popular weight loss drug The Financial Express13:00 20-Jan-25

Paytm shares slide 3%. Read to know what is worrying investors… The Financial Express08:44 20-Jan-25

Gautam Adani-led Adani Group appoints two US law firms to defend company in US indictment case The Financial Express08:21 20-Jan-25

Black-market weight drugs put hundreds in hospital with diarrhoea and vomiting Metro.co.uk17:29 19-Jan-25

High-dose semaglutide ramps up weight loss, says Novo pharmaphorum12:21 19-Jan-25

Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried? The Motley Fool09:25 19-Jan-25

Weight loss pills Ozempic, Wegovy and Trizepatide enter indian market The Financial Express03:01 19-Jan-25

In the last month

3 Unstoppable Stocks to Buy in 2025 The Motley Fool11:43 18-Jan-25

Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying Opportunity? The Motley Fool11:12 18-Jan-25

Online Sellers of Compounded GLP-1s Often Don't Mention Risks Medpage Today20:17 17-Jan-25

Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy. BioPharma Dive20:12 17-Jan-25

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s? TCTMD20:00 17-Jan-25

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today The Motley Fool16:39 17-Jan-25

The Good and Bad Side Effects of Weight Loss Drugs Men's Health15:43 17-Jan-25

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations Yahoo! US14:48 17-Jan-25

Weight loss medicines in England The House of Commons Library blog14:39 17-Jan-25

I lost four stone on weight loss jab Mounjaro and the side effects were worth it Yahoo! UK & Ireland11:46 17-Jan-25

JPM 2025: WuXi AppTec rebuffs concern about lower GLP-1 demand after Lilly’s low revenue… Pharmaceutical Technology22:04 16-Jan-25

WATCH: 1st Drug Approved For Sleep Apnea Patients Patch17:06 16-Jan-25

Sixty seconds on . . . food noise British Medical Journal16:27 16-Jan-25

My 10 Top Stocks to Buy to Start the New Year Off Right The Motley Fool08:24 16-Jan-25

Hanmi Pharmaceutical steps up in global obesity drug race The Korea Herald02:55 16-Jan-25

Scholar Rock Sets Sights on $2 Billion Apitegromab Revenue Amid Spinal Muscular Atrophy Market Growth Benzinga19:42 15-Jan-25

NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow Down Zacks18:05 15-Jan-25

Lilly v. FDA: Two Stories Collide to Make this GLP-1 Case a Tale of Our Time JD Supra16:52 15-Jan-25

Weight-loss doctor reveals alarming new symptom he's seeing in Ozempic patients MailOnline16:42 15-Jan-25

Key Drugs to Watch for Community Pharmacy in 2025 Pharmacy Times13:10 15-Jan-25

Lilly trims sales forecast on weaker obesity/diabetes growth pharmaphorum13:04 15-Jan-25

Here’s why Eli Lilly stock is crashing Finance in Bold12:43 15-Jan-25

LLY Stock Down on Lower-Than-Expected Sales Guidance for Q4 Zacks12:30 15-Jan-25

JP Morgan 2025: Eli Lilly misses 2024 revenue estimate by $400m Pharmaceutical Technology11:40 15-Jan-25

Obesity needs a new definition, says global commission pharmaphorum09:41 15-Jan-25

J.P. Morgan Notebook: New Launches Are Delivering Big For Big Pharma Scrip Pharma Intelligence02:54 15-Jan-25

Eli Lilly stock tumbles after new forecasts show weight-loss drug sales grow slower than… Yahoo! UK & Ireland20:19 14-Jan-25

Eli Lilly stumbles as weight-loss drug sales less than expected Proactive Investors (US)19:09 14-Jan-25

Eli Lilly stock down on Q4 guidance miss Yahoo! UK & Ireland19:08 14-Jan-25

Eli Lilly lowers FY revenue forecast as weight loss drug sales fall short Proactive Investors (US)18:18 14-Jan-25

Looking to slim down? Weight-loss drugs more effective than traditional dieting methods University of Ottawa (Press Release)17:25 14-Jan-25

Eli Lilly was hoping for even greater weight loss drug demand Quartz16:25 14-Jan-25

Regeneron Pipeline Aims To Address $220 Billion Therapeutic Opportunities By 2030 Benzinga16:16 14-Jan-25

Obesity rate drops in the U.S., healthcare experts point to GLP-1 medications as the cause WSFA TV 12, Alabama15:38 14-Jan-25

Persona launches personalized GLP-1 support platform NutraIngredients-USA.com15:36 14-Jan-25

Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks Benzinga15:23 14-Jan-25

Tragic Details About Dog The Bounty Hunter's Daughter Bonnie The List15:10 14-Jan-25

What is Mounjaro? Everything to know about NHS approved weight loss jab Daily Record15:05 14-Jan-25

Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff Medpage Today14:40 14-Jan-25

Next Generation Telehealth Platform Launches, Combining Medications And Personalized Supplements PR Newswire (Press Release)13:58 14-Jan-25

What Does It Mean to Microdose Ozempic? Next Avenue12:11 14-Jan-25

Get healthy in the new year? Don't fall for weight-loss drug scams ABC15.com, Arizona21:30 13-Jan-25

UB pharmacy professor discusses pros and cons of popular weight-loss drugs University at Buffalo18:07 13-Jan-25

ASHP Midyear: Expert Discusses the GLP-1 Landscape for Diabetes Care Pharmacy Times17:46 13-Jan-25

Mounjaro Update: Week 32 The Nittany Turkey (Weblog)17:04 13-Jan-25

2025 predictions: Which trends are set to shape the biotech industry this year? Labiotech14:02 13-Jan-25

Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1… GlobeNewswire (Press Release)12:08 13-Jan-25

Regeneron Provides Business Updates and Highlights from Broad Clinical Pipeline at the 43rd Annual J.P. Morgan… Regeneron Pharmaceuticals (Press Release)11:37 13-Jan-25

Nine-month-old obesity player Metsera files an IPO pharmaphorum10:12 13-Jan-25

Mediar Therapeutics signs licensing deal with Eli Lilly for IPF treatment Pharmaceutical Technology09:31 13-Jan-25

I tried Ozempic microdosing, the secret way the rich lose weight New Zealand Herald02:11 11-Jan-25

Potential blockbuster drugs to watch in 2025 European Pharmaceutical Review23:58 10-Jan-25

INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against BioAge Labs, Inc. (NASDAQ: BIOA); DiCello Levitt LLP… GlobeNewswire (Press Release)21:16 10-Jan-25

Advancing obesity drug discovery: Cell-based assays for GLP-1 and the G-Suite Drug Target Review11:15 10-Jan-25

The Derm Project to bring aesthetic medical ... Community Impact Newspaper21:18 9-Jan-25

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review TCTMD20:54 9-Jan-25

Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference Benzinga19:16 9-Jan-25

UK obesity rates may start falling this year thanks to weight loss jabs Manchester Evening News19:06 9-Jan-25

Global Biotechnology Market Outlook 2025: Driving Growth at 13.0% CAGR | MarketsandMarkets™ PR Newswire (Press Release)15:44 9-Jan-25

NVO Stock Up 3% as UBS Upgrades Company Rating From Neutral to Buy Zacks14:35 9-Jan-25

GLP-1 drugs may reduce surgery complications in patients with diabetes Cornell Chronicle14:34 9-Jan-25

Virginia Hospital Indicted; HHS Advice for RFK Jr.; Matt Damon Joins Debt Effort Medpage Today14:26 9-Jan-25

Medicare To Cover Eli Lilly's Weight Loss Drug Zepbound For Obstructive Sleep Apnea Treatment Benzinga14:22 9-Jan-25

F45 Training Expands Partnership With Dr. B to Support Prescription Weight Loss Programs With… Business Wire (Press Release)13:32 9-Jan-25

LLY Falls Around 14% in 3 Months: How to Play the Stock Zacks12:33 9-Jan-25

UK-based Verdiva launches with $410m and an oral GLP-1RA candidate Pharmaceutical Technology12:05 9-Jan-25

Zepbound can now be covered by Medicare Quartz22:31 8-Jan-25

view more headlines

26 Jan 13:19

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.